RIBAVIRIN - is an antiviral agent. It quickly penetrates and acts inside virus-infected cells. Ribavirin can be used to treat viral hemorrhagic fevers (viruses that can cause bleeding inside and outside of the body, problems with many organs, and death). In the event of biological warfare, Ribavirin may be used to treat viral hemorrhagic fever that has been spread deliberately and to treat severe acute respiratory syndrome (SARS a virus that may cause breathing problems, pneumonia, and death). Talk to your doctor about the possible risks of using this drug for your condition.
100% original from Russian pharmaceutical company Vertex.
All packs are air tight sealed and expire up to 03.2022.
Photos of the product are for illustation purpose only and may vary according to the manufacturer.
Ribavirin is a guanosine (ribonucleic) analog used to stop viral RNA synthesis and viral mRNA capping, thus, it is a nucleoside inhibitor. Ribavirin is a prodrug, which when metabolized resembles purine RNA nucleotides. In this form, it interferes with RNA metabolism required for viral replication. Over five direct and indirect mechanisms have been proposed for its mechanism of action. Ribavirin was first made in 1972 by researchers from International Chemical and Nuclear Corporation. It was reported that Ribavirin was active against a variety of RNA and DNA viruses in culture and in animals, without undue toxicity.
RIBAVIRIN comes in the form of tablets for oral use: 200 mg per tablet, 60 tablets per pack.
Ribavirin - 200 mg.
Lactose Monohydrate - 91.0 mg Corn Starch - 30.0 mg Povidone (Low Molecular Weight) - 22.0 mg Colloidal Silicon Dioxide - 5.0 mg Calcium Stearate - 2.0 mg
Hard Gelatin Capsules:
Titanium dioxide - 2% Iron Oxide Yellow (Iron Oxide) - 0.629% Gelatin - up to 100%.
Ribavirin is taken orally during meals, without chewing, with water.
Standard recommended dose is for patients with body weight less than 75 kg - 1000 mg per day (400 mg in the morning and 600 mg in the evening), patients with body weight more than 75 kg - 1200 mg per day (600 mg in the morning and evening).
The duration of the combination therapy with alpha-interferon is 24-48 weeks. For previously untreated patients - at least 24 weeks for patients with genotype I virus - 48 weeks for patients who are immune to monotherapy with alpha-interferon and with a relapse of the disease - at least 6 months.
Allergic reactions, cough, heartburn, digestive discomfort, loss of appetite, dry mouth, sweating.
Store in dry place at room temperature. Do not exceed storage temperature higher than 20 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about RIBAVIRIN.
|The purpose of the medication||Immune System|